• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于间充质干细胞治疗小鼠急性肝损伤期间肠道微生态的特征

Characteristics of Intestinal Microecology during Mesenchymal Stem Cell-Based Therapy for Mouse Acute Liver Injury.

作者信息

Dong Xiaotian, Feng Xudong, Liu Jingqi, Xu Yanping, Pan Qiaoling, Ling Zongxin, Yu Jiong, Yang Jinfeng, Li Lanjuan, Cao Hongcui

机构信息

State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Rd., Hangzhou City 310003, China.

Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, 79 Qingchun Rd., Hangzhou City 310003, China.

出版信息

Stem Cells Int. 2019 Feb 5;2019:2403793. doi: 10.1155/2019/2403793. eCollection 2019.

DOI:10.1155/2019/2403793
PMID:30867666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6379839/
Abstract

BACKGROUND

The mechanisms of mesenchymal stem cell (MSC) transplantation to protect against acute liver injury have been well studied within the liver. However, the associated changes in the intestinal microbiota during this process are poorly understood.

METHODS

In this study, compact bone-derived MSCs were injected into mice after carbon tetrachloride (CCl) administration. Potential curative effect of MSC was evaluated by survival rate and biochemical and pathological results. Overall structural changes of microbial communities and alterations in the intestinal microbiota were assessed by sequenced 16S rRNA amplicon libraries from the contents of the cecum and colon.

RESULTS

MSCs significantly reduced the serum levels of aspartate transaminase and alanine transaminase and improved the histopathology and survival rate. Lower expression and discontinuous staining of zonula occludens, as well as disrupted tight junctions, were observed in CCl-treated mice at 48 h compared with MSC-transplanted mice. Moreover, MSC transplantation to the liver leads to intestinal microbiota changes that were reflected in the decreased abundance of Bacteroidetes and and increased abundance of Firmicutes , , and at the initial time point compared with that in CCl-treated mice. In addition, phylogenetic investigation of communities by the reconstruction of unobserved states (PICRUSt) based on the Greengenes database revealed functional biomarkers of MSC-transplanted mice involved in cell motility, signal transduction, membrane transport, transcription, and metabolism of lipids, cofactors, vitamins, terpenoids, and polyketides, as well as xenobiotics.

CONCLUSION

The initial alterations in the Firmicutes/Bacteroidetes ratio, which resulted from MSC infusion to the liver, maintain intestinal mucosal biology and homeostasis that may be beneficial to liver repair.

摘要

背景

间充质干细胞(MSC)移植对急性肝损伤的保护机制在肝脏内已得到充分研究。然而,在此过程中肠道微生物群的相关变化却知之甚少。

方法

在本研究中,在给予小鼠四氯化碳(CCl)后,将致密骨源性MSC注射到小鼠体内。通过生存率、生化和病理结果评估MSC的潜在治疗效果。通过对盲肠和结肠内容物的16S rRNA扩增子文库进行测序,评估微生物群落的整体结构变化和肠道微生物群的改变。

结果

MSC显著降低了天冬氨酸转氨酶和丙氨酸转氨酶的血清水平,改善了组织病理学和生存率。与MSC移植小鼠相比,在48小时时,CCl处理的小鼠中紧密连接蛋白表达降低且染色不连续,以及紧密连接被破坏。此外,与CCl处理的小鼠相比,将MSC移植到肝脏导致肠道微生物群发生变化,在初始时间点表现为拟杆菌门丰度降低,厚壁菌门、、和丰度增加。此外,基于Greengenes数据库通过未观察状态的重建(PICRUSt)对群落进行系统发育研究,揭示了MSC移植小鼠的功能生物标志物,这些标志物涉及细胞运动、信号转导、膜转运、转录以及脂质、辅因子、维生素、萜类化合物、聚酮化合物以及外源性物质的代谢。

结论

由于向肝脏输注MSC导致的厚壁菌门/拟杆菌门比例的初始变化,维持了肠道黏膜生物学和内环境稳态,这可能有利于肝脏修复。

相似文献

1
Characteristics of Intestinal Microecology during Mesenchymal Stem Cell-Based Therapy for Mouse Acute Liver Injury.基于间充质干细胞治疗小鼠急性肝损伤期间肠道微生态的特征
Stem Cells Int. 2019 Feb 5;2019:2403793. doi: 10.1155/2019/2403793. eCollection 2019.
2
Characteristics of mouse intestinal microbiota during acute liver injury and repair following 50% partial hepatectomy.50%肝部分切除术后急性肝损伤及修复过程中小鼠肠道微生物群的特征
Exp Ther Med. 2021 Sep;22(3):953. doi: 10.3892/etm.2021.10385. Epub 2021 Jul 5.
3
Recovery Dynamics of Intestinal Bacterial Communities of CCl-Treated Mice with or without Mesenchymal Stem Cell Transplantation over Different Time Points.CCl 处理的小鼠肠道细菌群落在不同时间点的恢复动态,有无间充质干细胞移植的情况。
Biomed Res Int. 2020 Oct 14;2020:1673602. doi: 10.1155/2020/1673602. eCollection 2020.
4
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice.微囊化人骨髓间充质干细胞可减少小鼠肝纤维化。
J Hepatol. 2015 Mar;62(3):634-41. doi: 10.1016/j.jhep.2014.10.030. Epub 2014 Oct 30.
5
Bone marrow or adipose tissue mesenchymal stem cells: Comparison of the therapeutic potentials in mice model of acute liver failure.骨髓或脂肪组织间充质干细胞:在急性肝衰竭小鼠模型中治疗潜力的比较。
J Cell Biochem. 2018 Jul;119(7):5834-5842. doi: 10.1002/jcb.26772. Epub 2018 Mar 25.
6
Functional analysis of the relationship between intestinal microbiota and the expression of hepatic genes and pathways during the course of liver regeneration.肝脏再生过程中肠道微生物群与肝脏基因表达及信号通路之间关系的功能分析。
J Hepatol. 2016 Mar;64(3):641-50. doi: 10.1016/j.jhep.2015.09.022. Epub 2016 Jan 12.
7
Mesenchymal stem cells: In vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats.间充质干细胞:体内治疗应用改善四氯化碳诱导的大鼠肝纤维化。
Int J Biochem Cell Biol. 2015 Nov;68:109-18. doi: 10.1016/j.biocel.2015.09.003. Epub 2015 Sep 11.
8
Modulation of duodenal and jejunal microbiota by rifaximin in mice with CCl-induced liver fibrosis.利福昔明对四氯化碳诱导的肝纤维化小鼠十二指肠和空肠微生物群的调节作用。
Gut Pathog. 2023 Mar 21;15(1):14. doi: 10.1186/s13099-023-00541-4.
9
Hepatocyte-like Versus Mesenchymal Stem Cells in CCl4-induced Liver Fibrosis.四氯化碳诱导肝纤维化中肝细胞样细胞与间充质干细胞的比较
Appl Immunohistochem Mol Morphol. 2017 Nov/Dec;25(10):736-745. doi: 10.1097/PAI.0000000000000373.
10
Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.骨髓间充质干细胞对肝硬化小鼠模型缺氧及转化生长因子β1(TGFβ-1)和 SMADs 通路的影响。
Med Sci Monit. 2019 Sep 24;25:7182-7190. doi: 10.12659/MSM.916428.

引用本文的文献

1
Unraveling the interplay between mesenchymal stem cells, gut microbiota, and systemic sclerosis: therapeutic implications.解析间充质干细胞、肠道微生物群与系统性硬化症之间的相互作用:治疗意义
Microbiol Spectr. 2025 Jun 3;13(6):e0157624. doi: 10.1128/spectrum.01576-24. Epub 2025 Apr 24.
2
Mesenchymal Stem Cell-Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?间充质干细胞来源的外泌体在各种慢性肝病中的应用:炒作还是希望?
J Inflamm Res. 2024 Jan 10;17:171-189. doi: 10.2147/JIR.S439974. eCollection 2024.
3
Human umbilical cord mesenchymal stem cells regulate immunoglobulin a secretion and remodel the diversification of intestinal microbiota to improve colitis.

本文引用的文献

1
Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis.肠道微生物组的改变可表征小鼠临床前炎症性关节炎,并可调节其减轻已建立的关节炎。
Sci Rep. 2017 Nov 15;7(1):15613. doi: 10.1038/s41598-017-15802-x.
2
Historical Perspectives and Advances in Mesenchymal Stem Cell Research for the Treatment of Liver Diseases.历史视角与间充质干细胞治疗肝脏疾病研究的进展。
Gastroenterology. 2018 Jan;154(1):46-56. doi: 10.1053/j.gastro.2017.09.049. Epub 2017 Oct 26.
3
Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.
人脐带间充质干细胞调节免疫球蛋白 A 的分泌并重塑肠道微生物群的多样化以改善结肠炎。
Front Cell Infect Microbiol. 2022 Sep 2;12:960208. doi: 10.3389/fcimb.2022.960208. eCollection 2022.
4
Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota.人脐带间充质干细胞通过使肠道微生物群正常化来改善实验性结肠炎。
Stem Cell Res Ther. 2022 Sep 14;13(1):475. doi: 10.1186/s13287-022-03118-1.
5
Characterising the Intestinal Bacterial and Fungal Microbiome Associated With Different Cytokine Profiles in Two Pre-Treated Rats With D-Galactosamine-Induced Liver Injury.表征两种用半乳糖胺诱导肝损伤预处理大鼠不同细胞因子谱相关的肠道细菌和真菌微生物组。
Front Immunol. 2022 Mar 24;13:791152. doi: 10.3389/fimmu.2022.791152. eCollection 2022.
6
hUC-MSCs: evaluation of acute and long-term routine toxicity testing in mice and rats.人脐带间充质干细胞:小鼠和大鼠急性及长期常规毒性试验评估
Cytotechnology. 2022 Feb;74(1):17-29. doi: 10.1007/s10616-021-00502-2. Epub 2022 Jan 5.
7
Multiple Intestinal Bacteria Associated with the Better Protective Effect of LI09 against Rat Liver Injury.与 LI09 对大鼠肝损伤的更好保护作用相关的多种肠道细菌。
Biomed Res Int. 2022 Jan 28;2022:8647483. doi: 10.1155/2022/8647483. eCollection 2022.
8
Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson's Disease Mouse Model Through Regulating Intestinal Microorganisms.人脐带间充质干细胞通过调节肠道微生物改善帕金森病小鼠模型的运动功能
Front Cell Dev Biol. 2022 Jan 20;9:808905. doi: 10.3389/fcell.2021.808905. eCollection 2021.
9
Protective Effect of 1201 Combined with Galactooligosaccharide on Carbon Tetrachloride-Induced Acute Liver Injury in Mice.1201 联合半乳糖寡糖对四氯化碳诱导的小鼠急性肝损伤的保护作用。
Nutrients. 2021 Dec 12;13(12):4441. doi: 10.3390/nu13124441.
10
MSCs Therapy Reverse the Gut Microbiota in Hypoxia-Induced Pulmonary Hypertension Mice.间充质干细胞疗法逆转缺氧诱导的肺动脉高压小鼠的肠道微生物群。
Front Physiol. 2021 Aug 31;12:712139. doi: 10.3389/fphys.2021.712139. eCollection 2021.
间质干细胞依赖的肝脏疾病调控
Int J Biol Sci. 2017 Sep 5;13(9):1109-1117. doi: 10.7150/ijbs.20240. eCollection 2017.
4
Concise Review: Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction Following Trauma or Sepsis.简要综述:间充质干(基质)细胞:创伤或脓毒症后器官功能障碍治疗潜力的生物学及临床前证据
Stem Cells. 2017 Feb;35(2):316-324. doi: 10.1002/stem.2551. Epub 2017 Jan 19.
5
Induction of hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells by defined microRNAs.特定微小RNA诱导人脐带间充质干细胞分化为肝样细胞
J Cell Mol Med. 2017 May;21(5):881-893. doi: 10.1111/jcmm.13027. Epub 2016 Nov 22.
6
The intestinal epithelial barrier: a therapeutic target?肠上皮屏障:一个治疗靶点?
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):9-21. doi: 10.1038/nrgastro.2016.169. Epub 2016 Nov 16.
7
High fat diet induced atherosclerosis is accompanied with low colonic bacterial diversity and altered abundances that correlates with plaque size, plasma A-FABP and cholesterol: a pilot study of high fat diet and its intervention with Lactobacillus rhamnosus GG (LGG) or telmisartan in ApoE mice.高脂饮食诱导的动脉粥样硬化伴有结肠细菌多样性降低以及丰度改变,这些改变与斑块大小、血浆A-FABP和胆固醇相关:一项关于高脂饮食及其用鼠李糖乳杆菌GG(LGG)或替米沙坦对载脂蛋白E小鼠进行干预的初步研究。
BMC Microbiol. 2016 Nov 8;16(1):264. doi: 10.1186/s12866-016-0883-4.
8
Signals from the gut microbiota to distant organs in physiology and disease.来自肠道微生物群的信号在生理和疾病状态下对远处器官的作用。
Nat Med. 2016 Oct;22(10):1079-1089. doi: 10.1038/nm.4185. Epub 2016 Oct 6.
9
Gut microbiota and Toll-like receptors set the stage for cytokine-mediated failure of antibacterial responses in the fibrotic liver.肠道微生物群和Toll样受体为细胞因子介导的纤维化肝脏抗菌反应失败奠定了基础。
Gut. 2017 Mar;66(3):396-398. doi: 10.1136/gutjnl-2016-312486. Epub 2016 Sep 21.
10
The role of the gut microbiota in NAFLD.肠道微生物群在非酒精性脂肪性肝病中的作用。
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25. doi: 10.1038/nrgastro.2016.85. Epub 2016 Jun 8.